Page last updated: 2024-10-29

nsc 664704 and Myocardial Ischemia

nsc 664704 has been researched along with Myocardial Ischemia in 1 studies

kenpaullone: inhibits CDK1/cyclin B; structure in first source
kenpaullone : An indolobenzazepine that is paullone in which the hydrogen at position 9 is replaced by a bromo substituent. It is an ATP-competitive inhibitor of cyclin-dependent kinases (CDKs) and glycogen synthase kinase 3beta (GSK3beta).

Myocardial Ischemia: A disorder of cardiac function caused by insufficient blood flow to the muscle tissue of the heart. The decreased blood flow may be due to narrowing of the coronary arteries (CORONARY ARTERY DISEASE), to obstruction by a thrombus (CORONARY THROMBOSIS), or less commonly, to diffuse narrowing of arterioles and other small vessels within the heart. Severe interruption of the blood supply to the myocardial tissue may result in necrosis of cardiac muscle (MYOCARDIAL INFARCTION).

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lee, SY1
Lee, S1
Choi, E1
Ham, O1
Lee, CY1
Lee, J1
Seo, HH1
Cha, MJ1
Mun, B1
Lee, Y1
Yoon, C1
Hwang, KC1

Other Studies

1 other study available for nsc 664704 and Myocardial Ischemia

ArticleYear
Small molecule-mediated up-regulation of microRNA targeting a key cell death modulator BNIP3 improves cardiac function following ischemic injury.
    Scientific reports, 2016, Mar-24, Volume: 6

    Topics: Animals; Benzazepines; Cell Death; Cells, Cultured; Disease Models, Animal; Heart Function Tests; In

2016